These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26596722)

  • 41. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians.
    Qaseem A; Crandall CJ; Mustafa RA; Hicks LA; Wilt TJ; ; Forciea MA; Fitterman N; Horwitch CA; Kansagara D; Maroto M; McLean RM; Roa J; Tufte J
    Ann Intern Med; 2019 Nov; 171(9):643-654. PubMed ID: 31683290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Key issues that need to be considered while revising the current annex of the European Council Recommendation (2003) on cancer screening.
    Ponti A; Basu P; Ritchie D; Anttila A; Carvalho AL; Senore C; Mallafré-Larrosa M; Piccinelli C; Ronco G; Soerjomataram I; Primic-Žakelj M; Dillner J; Elfström MK; Lönnberg S; Vale DB; Tomatis M; Armaroli P; Giordano L; Sankaranarayanan R; Segnan N
    Int J Cancer; 2020 Jul; 147(1):9-13. PubMed ID: 31970768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Peterse EFP; Meester RGS; Siegel RL; Chen JC; Dwyer A; Ahnen DJ; Smith RA; Zauber AG; Lansdorp-Vogelaar I
    Cancer; 2018 Jul; 124(14):2964-2973. PubMed ID: 29846933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indicators for monitoring screening programs with primary HPV test.
    Zorzi M; Giorgi Rossi P;
    Epidemiol Prev; 2017; 41(1 Suppl 1):1-32. PubMed ID: 28322534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus.
    Kim JJ; Burger EA; Sy S; Campos NG
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27754955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
    Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
    CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Current evidence and development of colorectal cancer screening in Germany].
    Haug U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1513-1516. PubMed ID: 30327833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colorectal cancer screening in Europe.
    Zavoral M; Suchanek S; Zavada F; Dusek L; Muzik J; Seifert B; Fric P
    World J Gastroenterol; 2009 Dec; 15(47):5907-15. PubMed ID: 20014454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cervical cancer screening: past--present--future].
    Breitenecker G
    Pathologe; 2009 Dec; 30 Suppl 2():128-35. PubMed ID: 19756616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registries.
    Anttila A; Lönnberg S; Ponti A; Suonio E; Villain P; Coebergh JW; von Karsa L
    Eur J Cancer; 2015 Jan; 51(2):241-51. PubMed ID: 25483785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians (Version 2).
    Qaseem A; Harrod CS; Crandall CJ; Wilt TJ; ; Balk EM; Cooney TG; Cross JT; Fitterman N; Maroto M; Obley AJ; Tice J; Tufte JE; Shamliyan T; Yost J
    Ann Intern Med; 2023 Aug; 176(8):1092-1100. PubMed ID: 37523709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
    Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
    Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary.
    von Karsa L; Patnick J; Segnan N
    Endoscopy; 2012 Sep; 44 Suppl 3():SE1-8. PubMed ID: 23012113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
    Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
    Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Early detection of cancer in the German National Cancer Plan: health policy and legal regulations].
    Helou A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):288-93. PubMed ID: 24562702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review.
    Caverly TJ; Hayward RA; Reamer E; Zikmund-Fisher BJ; Connochie D; Heisler M; Fagerlin A
    J Natl Cancer Inst; 2016 Jun; 108(6):djv436. PubMed ID: 26917630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.